News

Medium_logo-infrafrontier-2

Biomedcode participates at INFRAFRONTIER2020 Kick-Off meeting, April 24-25th in Munich

INFRAFRONTIER aims to build a world-class research infrastructure that provides the biomedical research community with the tools needed to...

Read More
Medium_btcure

Biomedcode is participating at the BTCure Final meeting 5-7th of February 2017 in Prague

BTCure is an IMI project co-funded by the European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The...

Read More
Medium_metabolomics

Metabolic profiling of the Tg197 Arthritis mouse model reveals itaconic acid as a marker of Rheumatoid...

Biomedcode coauthors a publication in the Journal of Proteome Research on the identification of a biomarker with translational value for the...

Read More
Medium_news_sandoz

Biomedcode's human TNF transgenic arthritis model, (Tg197), contributes to the non-clinical assessment of...

In the evaluation process of the proposed biosimilar to Enbrel, GP2015, non-clinical data using the Tg197 model of arthritis confirmed its...

Read More
Medium_imq-tacrolimus

Biomedcode's mouse model offers the in vivo validation of the efficacy of an improved tacrolimus...

Biomedcode coauthors a publication in the Journal of Controlled Release on the in vivo non-clinical proof of  the efficacy of a novel...

Read More
Medium_btcure

Biomedcode is participating at the BTCure workshop on Animal models of Disease (18-20 Sept 2016) with talks...

BTCure is an IMI project co-funded by the European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The 4th...

Read More
Medium_frailty_mouseage_

Biomedcode coauthors a review paper on aging related frailty in mice and tools used for its assessment

Dr N.Karagianni, Biomedcode's CSO, participates as an expert at MouseAGE COST action a European network for preclinical testing of interventions in...

Read More
Medium_ccr9_spondyloarthritis-2

Biomedcode’s preclinical models: Priming drugs for success but also … predicting drug failure!

A new clinical study published by GlaxoSmithKline confirms findings in Biomedcode's TNF-DARE models.

Read More
Medium_transmembrane_tnf_driven_spondyloarthitis_tga86

Review: animal models as a tool to dissect pivotal pathways driving spondyloarthritis

A new review highlights Biomedcode's models of spondyloarthropathy

Read More
Medium_tg107-histology-b

A recent review in the Nature Reviews Immunology highlights the instrumental role of the Tg197 model of...

Brenner et al., 2015. "Regulation of tumour necrosis factor signalling: live or let die". Nat Rev Immunol. May 26;15(6):362-74.

Read More